Ferroptosis in diabetic retinopathy: from pathogenic mechanisms to translational prospects

Jieyu Jiang1,2, Zhimin Liu1, Xiangdong Chen1

  • 1The First Hospital of Hunan University of Chinese Medicine, Changsha, Hunan, China.

Frontiers in Endocrinology
|February 19, 2026
PubMed

Insights

Ferroptosis, a cell death pathway involving iron, plays a key role in diabetic retinopathy (DR) development. Understanding this link may lead to new treatments for DR.

Area of Science:

  • Ophthalmology
  • Cell Biology
  • Endocrinology

Background:

  • Diabetic retinopathy (DR) is a major microvascular complication of diabetes.
  • Current DR treatment strategies require optimization.
  • Understanding DR pathogenesis is crucial for developing new therapies.

Purpose of the Study:

  • To review the mechanisms of ferroptosis and its role in DR pathogenesis.
  • To explore iron metabolism abnormalities and signaling pathways in DR.
  • To identify potential ferroptosis inhibitors for DR treatment.

Main Methods:

  • Literature review of ferroptosis mechanisms.
  • Analysis of studies linking ferroptosis to DR.
  • Exploration of iron metabolism and signaling pathways in DR.

Main Results:

  • Ferroptosis is increasingly recognized as a contributor to DR pathology.
  • Abnormal iron metabolism and related pathways are implicated in DR.
  • Several compounds show potential as ferroptosis inhibitors for DR.

Conclusions:

  • Ferroptosis is a significant factor in diabetic retinopathy.
  • Targeting ferroptosis pathways presents a promising therapeutic avenue for DR.
  • Further research into iron metabolism and ferroptosis inhibitors is warranted for DR management.